The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennant International Regulatory News (PEN)

Share Price Information for Pennant International (PEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 31.00
Bid: 30.00
Ask: 32.00
Change: -0.50 (-1.59%)
Spread: 2.00 (6.667%)
Open: 31.50
High: 31.50
Low: 31.00
Prev. Close: 31.50
PEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update & Notice of Interim Results

28 Jul 2022 07:00

RNS Number : 0538U
Pennant International Group PLC
28 July 2022
 

 

FOR IMMEDIATE RELEASE 28 July 2022

PENNANT INTERNATIONAL GROUP PLC

Trading Update & Notice of Interim Results

 

Return to positive EBITA; business mix transformed; significant gross margin improvement

 

 

Pennant International Group plc (AIM:PEN) ("Pennant", the "Group" or "Company"), a leading global provider of training technology and integrated product support solutions, issues the following trading update for the six months ended 30 June 2022 (the "First Half"). The Company expects to publish its Interim Results on 21 September 2022.

 

Financial Summary

 

A preliminary unaudited assessment of the Group's trading for the First Half indicates:

 

· revenues of £6.9 million (H1 2021: £7.4 million) of which circa 65% are recurring;

· 52% of revenues generated from software licensing and associated activities (H1 2021: 35%);

· gross margin of 41% (H1 2021: 21%);

· earnings before interest, taxation and amortisation of £0.1 million (H1 2021: EBITA loss of £1.0 million);

· net debt at period end of £4.1 million (H1 2021: £1.9 million), see 'Working Capital' section below; and

· three-year order book at period end of £27 million (H1 2021: £26 million).

 

Revenue Composition

 

Revenues by region and by workstream during the First Half were as follows:

 

Revenue by region

£m

 

Revenue by workstream

£m

UK, Europe & Middle East

2.7

Engineered Solutions

1.4

North America

2.4

Generic Products

0.4

Australasia

1.8

Technical Services

1.5

Total

6.9

Software Product/Licences

0.6

Software Maintenance

0.8

Software Services

2.2

Total

6.9

 

Programme Delivery

 

An update is provided below on the Group's key 'engineered-to-order' programmes:

 

GD MTE: the first two devices were delivered to the end user's site during the First Half. One of the devices has successfully passed site acceptance testing while the other enters testing early next month. The second two devices are scheduled to be delivered to an alternative site in September once the relevant facility has been commissioned ready for their arrival. The programme is on schedule to be completed before year-end.

 

UK Helicopter programme: Under this contract with a UK OEM (worth c. £3.5 million), Pennant is required to convert a real helicopter airframe into a systems trainer. The finished training device was delivered to the end user's site during the First Half and has successfully passed site acceptance. All events and milestones to date have been passed and paid in full and the programme is scheduled to complete shortly.

 

UK Apache upgrade progamme: Pennant has been contracted by Boeing Defence United Kingdom Limited to upgrade Apache Mk 1 training devices to align with the Mk 2 variant (contract value: £8.8 million). The first engineering event was held and passed during the First Half, and the associated milestone payment has been invoiced and paid in full post period end.

 

Working Capital

 

The Group's net debt position is expected to materially improve during the second half, as invoices on the above three programmes, and other contracts, are raised and settled. The sale of the Group's under-utilised Pennant Court facility is well-progressed, with exchange of contracts imminent. The sale value is in excess of the bank's security value and the transaction is anticipated to be significantly cash positive, providing additional working capital and funds for product investment if needed.

 

Global Economic Situation

 

Like most businesses, the Group is experiencing certain pressures from inflation in all key regions. The Group is keeping its pricing policy and supply chain arrangements under review and where contracts contain escalation mechanisms to respond to inflation these are being monitored. To help our staff during this time, and to ensure key employees can be recruited and retained during this period of intense wage competition, the Group has awarded all staff a mid-year pay rise.

 

 

 

 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

Enquiries:

 

Pennant International Group plc

www.pennantplc.co.uk

Philip Walker, CEO

David Clements, Commercial & Risk Director 

+44 (0) 1452 714 914

WH Ireland Limited (Nomad and Broker)

www.whirelandcb.com

Mike Coe

Sarah Mather

+44 (0) 20 7220 1666

Walbrook PR (Financial PR)

paul.vann@walbrookpr.com

Paul Vann

Tom Cooper

+44 (0)20 7933 8780

Mob: +44 (0)7768 807631

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTRPMATMTTTMRT
Date   Source Headline
1st Nov 20211:23 pmRNSHolding in Company
28th Oct 20212:26 pmRNSHolding in Company
12th Oct 20212:44 pmRNSGrant of Option
30th Sep 20215:02 pmRNSHolding in Company
28th Sep 20214:31 pmRNSHolding in Company
27th Sep 20215:02 pmRNSHolding(s) in Company
23rd Sep 20217:00 amRNSDirector/PDMR Share Purchases
22nd Sep 20217:00 amRNS2021 Interim Results
7th Sep 20212:44 pmRNSHolding in Company
31st Aug 20212:05 pmRNSSecond Price Monitoring Extn
31st Aug 20212:00 pmRNSPrice Monitoring Extension
31st Aug 20217:00 amRNSTrading Update & Notice of Interim Results
2nd Jun 20214:48 pmRNSResults of AGM & Appointment of new Chairman
27th May 20217:00 amRNSAGM Update
29th Apr 20213:31 pmRNSNotice of AGM
28th Apr 20212:05 pmRNSSecond Price Monitoring Extn
28th Apr 20212:00 pmRNSPrice Monitoring Extension
28th Apr 20217:00 amRNS2020 Final Results
19th Apr 20217:00 amRNSRescheduling of 2020 Final Results
1st Apr 20214:46 pmRNSIssue of Equity & Director Dealings
10th Mar 20217:00 amRNSNotice of Final Results
9th Mar 20217:00 amRNSHoldings in Company
9th Mar 20217:00 amRNSHoldings in Company
6th Oct 20202:00 pmRNSHolding(s) in Company
6th Oct 20202:00 pmRNSHolding(s) in Company
5th Oct 202011:02 amRNSHolding(s) in Company
5th Oct 202011:01 amRNSHolding(s) in Company
5th Oct 202011:00 amRNSHolding(s) in Company
21st Sep 20207:00 amRNS2020 Interim Results
11th Sep 20207:00 amRNSHolding(s) in Company
11th Sep 20207:00 amRNSHolding(s) in Company
8th Sep 20207:00 amRNSHoldings in Company
13th Aug 20207:00 amRNSTrading Update & Notice of Interim Results
29th Jul 20203:47 pmRNSDirector/PDMR Shareholding
17th Jul 20207:00 amRNSNew Contract & Notice of Half-Year Trading Update
22nd May 20207:00 amRNSBusiness Update
15th May 202012:00 pmRNSResult of AGM
20th Apr 20201:58 pmRNSIssue of Equity and Director Dealing
20th Apr 20207:00 amRNS2019 Preliminary Results
25th Mar 20207:00 amRNSCovid-19 Update
16th Mar 202012:51 pmRNSNotice of Results
10th Mar 202012:00 pmRNSContract Update
3rd Mar 202010:00 amRNSCompletion of Australian Acquisition
19th Feb 20207:00 amRNSStatement of Intent for Prospective £5m Contract
7th Feb 202011:08 amRNSHolding(s) in Company
3rd Feb 20207:00 amRNSContract Wins
3rd Feb 20207:00 amRNSTrading Update
22nd Jan 20204:58 pmRNSHoldings in Company
21st Jan 20207:00 amRNS£3.44m Australian Acquisition
22nd Nov 20197:00 amRNSBoard Re-organisation & Directorate Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.